This is the first article in a two-part report.
James A Shannon, director of the US National Institutes of Health 1955-68, said: ‘No vaccination can be proven safe before it is given to children.’
When he made that statement, it was still possible in the US to sue vaccine manufacturers under tort law for vaccine-induced deaths and injuries, which is no longer the case.
Today the US has the world’s most aggressive vaccine schedule and ranks as the sickest country, with the highest infant mortality, in the developed world. The UK does not lag far behind.
Vaccines carry three separate areas of potential risk. Firstly, they artificially stimulate the immune system to produce antibodies, which temporarily inhibits another part of the body’s defence mechanism. In an infant, whose immune system is just developing, this high demand of energy can in some cases overwhelm its metabolic reserves, and cause brain inflammation. The brain is the highest energy-consuming tissue in the body, followed by the gastro-intestinal tract and the immune system.
Secondly, vaccines contain chemicals, metals and drugs. Thirdly, according to the former pharmaceutical R&D executive Sasha Latypova, traditional vaccines are consistently contaminated with plant and animal proteins which hyper-sensitise the body, especially in children, giving rise to allergies.
In the US in the 1970s there were three inoculations recommended for children: the combined diphtheria, tetanus and pertussis (whooping cough) (DTP), polio, and the combined measles, mumps and rubella (MMR), introduced there in 1971. The DTP which was used in the US until 1992 contained the carcinogen formaldehyde. Both the DTP and the MMR contained the preservative thimerosal, which is almost 50 per cent mercury, and in infants can pass through the blood-brain barrier.
A wave of sudden infant deaths (SIDs), severe brain injuries, seizures and other neurological problems were linked through studies to the DTP. In 1977, a study published in the Lancet established that the risks of the whole-cell pertussis used in the DTP vaccine exceeded the risks associated with wild pertussis. Six years later, in 1983, a National Institutes of Health-funded study found that Wyeth’s DTP vaccine was killing or causing severe brain damage to 1 in 300 vaccinated children.
Lawsuits against the manufacturers shot up. In 1984, the president of pharmaceutical manufacturer Lederle declared that the dollar demand of DTP lawsuits against the company was 200 times greater than their total sales of DTP vaccine in 1983. Another vaccine manufacturer, Connaught Laboratories, had damages suits filed against it in 1985/6 amounting to a billion dollars. Wyeth, now Pfizer, faced a similar plight, and bankruptcy threatened the industry as insurers withdrew their indemnity cover.
The industry therefore lobbied Congress for a liability shield from damages, which led to the passing of the National Childhood Vaccine Injury Act in 1986, and the establishment of the Vaccine Injury Compensation Program (VICP) in 1988, administered by the US government through the Health and Human Services Department.
Parents of vaccine-injured children from 1988 were directed to apply to what is commonly referred to as the ‘Vaccine Court’ to present their cases. This was supposed to be a neutral forum where the adversarial nature of civil litigation was removed, their cases would be dealt with swiftly and compensation, where applicable, paid in a timely manner. The reality could not be more different, and how the ‘Vaccine Court’ actually operates will be described in Part 2.
Meanwhile, freed from any consequences and related costs of selling unsafe products, vaccine manufacturers wasted no time in creating new lucrative vaccines and lobbying Congress to include them in the Childhood Vaccine Schedule. That same year of 1988, Hepatitis B and the Hib vaccine, against haemophilus influenza type B, were introduced, both containing mercury-laden thimerosal. In The Real Anthony Fauci, Robert F Kennedy Jr writes that more than 450 studies attested to thimerosal’s devastating toxicity, and because testosterone amplifies the neurotoxicity of the mercury molecule, boys were disproportionately affected.
Cases of autism, ADHD, speech delay, and other neurological conditions soared, in direct parallel with the fast-expanding vaccine schedule. In 1986 autism cases in the US were approximately 1 in 2,500. By 2017 they had jumped to 1 in 36. From the three recommended vaccines in 1986, by 2017 the schedule had risen to 69 doses of 16 vaccines.
Not one paediatric vaccine has ever been tested for safety against a genuine placebo. In 2017 TV producer Del Bigtree asked the US Department of Health and Human Services (HHS) how it justified licensing any paediatric vaccine without first conducting a long-term clinical trial in which the rate of adverse reactions in the subject group was compared with a control group receiving an inert placebo. In January 2018 the HHS replied: ‘Inert placebo controls are not required to understand the safety profile of a new vaccine.’
If randomised control trials (RCTs), the so-called gold standard of safety testing, are kicked aside, how can any conclusions reached on the safety profile of a product be scientifically valid?
There are, however, real-life comparison studies between cohorts of vaccinated and unvaccinated children.
As reported by RFK Jr’s Children’s Health Defense, for years American paediatrician Paul Thomas, now retired, witnessed healthy 12-month-olds regress into severe autism following the MMR vaccination, so in 2010 he devised a new, bespoke approach to the vaccination of children in his practice Integrative Pediatric. He offered parents a comprehensive discussion and autonomy over whether to vaccinate their children as per the US schedule, selectively vaccinate them, with longer intervals between shots, or not vaccinate them at all.
As reported in TCW yesterday, he and colleague James Lyons-Weiler PhD studied the health outcomes of the children over almost ten years, and in 2020 published the results in a groundbreaking paper which showed unequivocally that unvaccinated children enjoy better health than vaccinated children. The results showed a dramatic reduction of cases of ADHD and autism. They were almost entirely absent in the unvaccinated cohort, and greatly reduced in the partially vaccinated cohort. The same applied to anaemia, asthma, allergies, dermatitis, eczema, ear and eye infections and sinusitis.
In a recent discussion with Paul Thomas, the mother of an autistic son explained that he had been developing normally until he received the MMR vaccine, when his temperature shot up, he came out in an appalling rash, and screamed incessantly while hitting his head against the wall. She said she kept telephoning her paediatrician, who said it was ‘normal’.
Dr Thomas explained that when paediatricians say it is ‘normal’, what they mean is it is ‘common’. Many in the medical profession have become so blinded by dogma that they see frequency as indicating normality and cease to recognise what is profoundly abnormal.
That one vaccine-generation child in two graduates from high school in the US taking medication for a chronic condition should be regarded as both highly abnormal and an indictment of US public health policy.
How this has been allowed is, at least in part, down to the corrupted working of the US Vaccine Court, and the total protection from liability this gives to Big Pharma and its profit driven vaccine enterprise, and I will discuss this in Part 2.
October 20, 2023
Posted by aletho |
Science and Pseudo-Science, Timeless or most popular | ADHD, Asthma, Autism, United States |
Leave a comment
In 2013, the National Vaccine Program Office of the U.S. Department of Health and Human Services (HHS) commissioned an update of earlier findings on the lack of evidence to support claims that the Centers for Disease Control and Prevention (CDC) infant/child vaccination schedule was safe.
The Institute of Medicine (IOM) committee, charged with producing the update, found that “few studies have comprehensively assessed the association between the entire immunization schedule or variations in the overall schedule and categories of health outcomes, and no study has directly examined health outcomes and stakeholder concerns in precisely the way that the committee was charged to address in its statement of task.”
According to the IOM committee, “studies designed to examine the long-term effects of the cumulative number of vaccines or other aspects of the immunization schedule have not been conducted.”
The lack of information on the overall safety of the vaccination schedule was so compelling that the committee then recommended HHS incorporate the study of the safety of the overall childhood immunization schedule into its processes for setting priorities for research, “recognizing stakeholder concerns, and establishing the priorities on the basis of epidemiological evidence, biological plausibility, and feasibility.”
The IOM also recommended the CDC use its private database, the Vaccine Safety Datalink (VSD), to study the overall health effects of the vaccination schedule using retrospective analyses.
Ten years later, the CDC has yet to do such a comparison study, even though it is sitting on a vast repository of data in the VSD, which include comprehensive medical records for more than 10 million individuals and 2 million children.
The VSD also contains records for a significant number of unvaccinated children, yet the CDC refuses to compare the health outcomes of vaccinated children to completely unvaccinated children.
The CDC also prohibits VSD outside researchers from accessing the VSD data so they can do the studies.
I was fortunate enough to be one of the researchers who had VSD access as I worked with Dr. Mark R. Geier and his son, David Geier, on a series of studies on thimerosal-containing vaccines in the early 2010s.
However, the CDC subsequently revoked the Geiers’ access because one of the health maintenance organizations (HMO) participating in the VSD project did not like the results the Geiers were obtaining, tying thimerosal exposure to a variety of childhood chronic disorders including autism spectrum disorder, attention-deficit/hyperactivity disorder (ADHD), birth defects, acute ethylmercury poisoning, fetal/infant/childhood death, premature puberty, emotional disturbance, tic disorder and developmental delays.
In Chapter 2 of “Vax-Unvax: Let the Science Speak,” Robert F. Kennedy Jr. and I present the very few studies completed on the entire infant/child vaccination schedule, including the groundbreaking study, “Pilot Comparative Study on the Health of Vaccinated and Unvaccinated 6- to 12-Year-Old U.S. Children,” by Anthony Mawson, doctor in public health.
Mawson and his co-authors studied fully vaccinated, partially vaccinated and unvaccinated home-schooled children for both infectious and chronic disease incidence.
Not only were chronic diseases more prominent in fully and partially vaccinated children — where the incidence of these diseases ranged from 30 times higher for allergic rhinitis to 3.7 times for neurodevelopmental disorders — but there also was a higher prevalence of infectious diseases like pneumonia and ear infections in vaccinated children.
In a separate 2017 study, “Preterm Birth, Vaccination and Neurodevelopmental Disorders: a Cross-Sectional Study of 6- to 12-Year-Old Vaccinated and Unvaccinated Children,” Mawson et al. also found that the risk of neurodevelopmental disorders among vaccinated children was compounded by low birth weight.
Low birth weight, vaccinated children were 14.5 times more likely to get a diagnosis compared to unvaccinated, normal birth weight children.
I also completed two studies with Neil Z. Miller on vaccinated versus unvaccinated children using medical records from six separate pediatric practices.
Our first study, “Analysis of Health Outcomes in Vaccinated and Unvaccinated Children: Developmental Delays, Asthma, Ear Infections and Gastrointestinal Disorders,” published in 2020, focused on vaccines administered during the first year of life and specific diagnoses occurring after the first birthday.
Those children who received one or more vaccines during their first year of life were 2.2 times more likely to be diagnosed with a developmental delay, 4.5 times more likely to be diagnosed with asthma and 2.1 times more likely to suffer from ear infections when compared to unvaccinated children.
In our second study, “Health Effects in Vaccinated versus Unvaccinated Children, with Covariates for Breastfeeding Status and Type of Birth,” published in 2021, we compared fully vaccinated, partially vaccinated and unvaccinated children for incidence of autism, ADHD, asthma, chronic ear infections, severe allergies and gastrointestinal disorders.
Most notably, fully vaccinated children were 5 times more likely to be diagnosed with autism, 17.6 times more likely to be diagnosed with asthma, 20.8 times more likely to be diagnosed with ADHD and 27.8 times more likely to be diagnosed with chronic ear infections compared to completely unvaccinated children.
In a separate analysis within this same study, we changed the statistical model to reflect breastfeeding status and type of birth (normal or Cesarean). Breastfed unvaccinated children fared much better than non-breastfed vaccinated children when comparing the incidence of autism, asthma, ADHD, gastrointestinal disorders, severe allergies and chronic ear infections.
We obtained similar results when investigating the type of birth and vaccination status.
James Lyons-Weiler, Ph.D., and Dr. Paul Thomas also published a study in 2021, “Relative Incidence of Office Visits and Cumulative Rates of Billed Diagnoses Along the Axis of Vaccination,” investigating children in Thomas’ Portland, Oregon, pediatric practice.
This study compared the relative incidence of office visits for different disorders between vaccinated and unvaccinated children. Lyons-Weiler and Thomas found significant increases in office visits among vaccinated children for fever, ear infections, conjunctivitis, asthma, breathing issues, anemia, eczema, behavioral issues, gastroenteritis, weight/eating disorders and respiratory infections.
Notably, there were no ADHD diagnoses among unvaccinated children, whereas the rate of diagnosis among vaccinated children was 5.3%.
Unfortunately, the International Journal of Environmental Research and Public Health retracted the study on the basis of a lone, anonymous complaint. Lyons-Weiler and Thomas were not allowed to rebut the complainant’s concerns regarding the healthcare-seeking behavior of families of unvaccinated children.
However, Lyons-Weiler fired back with Dr. Russell Blaylock in their 2022 paper, “Revisiting Excess Diagnoses of Illnesses and Conditions in Children Whose Parents Provided Informed Permission to Vaccinate Them,” published in the International Journal of Vaccine Theory, Practice, and Research — an article in which the authors definitively showed that vaccinated children tended to visit their pediatrician more not less than unvaccinated children, which affirmed their original analysis.
Chapter 2 of “Vax-Unvax” also highlights the 2022 study, “Association Between Aluminum Exposure From Vaccines Before Age 24 Months and Persistent Asthma at Age 24 to 59 Months,” by CDC scientists who used the VSD to calculate the level of aluminum exposure in infant vaccines administered up to 2 years of age.
The authors compared the health outcomes of children exposed to more than 3 milligrams of aluminum in their vaccines versus those exposed to less than 3 milligrams of aluminum.
Although this was not a true “vax-unvax” study as there was no unvaccinated control group (the CDC never includes one, unfortunately), Kennedy and I decided to include it in the book because of the study’s alarming findings.
The study authors found that children exposed to higher levels of aluminum were 1.36 times as likely to be diagnosed with persistent asthma prior to their 5th birthday.
Children diagnosed with eczema and exposed to the higher level of aluminum fared even worse and were 1.61 times as likely to be diagnosed with persistent asthma prior to their 5th birthday.
Each of these results was statistically significant, leading us to wonder what the risk of asthma would have been if the CDC had chosen to compare vaccinated children exposed to aluminum to an unvaccinated cohort of children.
“Vax-Unvax: Let the Science Speak” will be released Aug. 29 and is available for preorder on Amazon, Barnes & Noble and other online booksellers.
Brian S. Hooker, Ph.D., is senior director of science and research at Children’s Health Defense and professor emeritus of biology at Simpson University in Redding, California.
This article was originally published by The Defender — Children’s Health Defense’s News & Views Website under Creative Commons license CC BY-NC-ND 4.0. Please consider subscribing to The Defender or donating to Children’s Health Defense.
August 22, 2023
Posted by aletho |
Book Review, Science and Pseudo-Science, Timeless or most popular | ADHD, Asthma, Autism, CDC, United States |
1 Comment
Aletho News
Aletho News 